1. Home
  2. ADUS vs EVO Comparison

ADUS vs EVO Comparison

Compare ADUS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADUS
  • EVO
  • Stock Information
  • Founded
  • ADUS 1979
  • EVO 1993
  • Country
  • ADUS United States
  • EVO Germany
  • Employees
  • ADUS N/A
  • EVO N/A
  • Industry
  • ADUS Medical/Nursing Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADUS Health Care
  • EVO Health Care
  • Exchange
  • ADUS Nasdaq
  • EVO Nasdaq
  • Market Cap
  • ADUS 2.1B
  • EVO 1.5B
  • IPO Year
  • ADUS 2009
  • EVO 2021
  • Fundamental
  • Price
  • ADUS $110.83
  • EVO $4.07
  • Analyst Decision
  • ADUS Buy
  • EVO Buy
  • Analyst Count
  • ADUS 10
  • EVO 2
  • Target Price
  • ADUS $143.50
  • EVO $5.90
  • AVG Volume (30 Days)
  • ADUS 149.0K
  • EVO 112.1K
  • Earning Date
  • ADUS 08-04-2025
  • EVO 08-13-2025
  • Dividend Yield
  • ADUS N/A
  • EVO N/A
  • EPS Growth
  • ADUS 9.84
  • EVO N/A
  • EPS
  • ADUS 4.42
  • EVO N/A
  • Revenue
  • ADUS $1,211,561,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • ADUS $23.16
  • EVO $10.08
  • Revenue Next Year
  • ADUS $5.77
  • EVO $10.99
  • P/E Ratio
  • ADUS $24.91
  • EVO N/A
  • Revenue Growth
  • ADUS 11.38
  • EVO 1.50
  • 52 Week Low
  • ADUS $88.96
  • EVO $2.84
  • 52 Week High
  • ADUS $136.72
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • ADUS 44.79
  • EVO 47.66
  • Support Level
  • ADUS $109.93
  • EVO $4.12
  • Resistance Level
  • ADUS $115.01
  • EVO $4.26
  • Average True Range (ATR)
  • ADUS 2.69
  • EVO 0.11
  • MACD
  • ADUS -0.47
  • EVO -0.01
  • Stochastic Oscillator
  • ADUS 7.48
  • EVO 54.84

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: